Andres McAllister-arkiv - BioStock

BioInvent comments on the progress in the breast cancer study

BioInvent comments on breast cancer study progress

13 December, 2023

DexTech avancerar mot kliniska studier

BioInvent’s CMO comments on phase I/IIa data with BI-1808

27 June, 2023

BioInvent's CFO on the company's business strategy

BioInvent’s CFO on the company’s business strategy

9 May, 2023

BioInvent LLS TAP

CMO gives insight on new BioInvent collaboration

25 January, 2023

FDA

BioInvent’s CMO on the positive FDA decision

21 January, 2022

BioInvent’s CMO on new positive data with BI-1206

12 November, 2021